Introduction:

Li Zhifei was born into a medical family and has been engaged in oncology clinical work for more than 20 years. He has a solid theoretical foundation and rich clinical experience, and he has unique insights into various difficult tumor treatments. Dr. Li is good at minimally invasive treatment and molecular targeted drug therapy on advanced tumors, inoperable tumors and recurrent tumors.

Educational background:

Sun Yat-sen University Cancer Center

Medical experience:

Member of Chinese Medical Association

Member of China Anti-Cancer Association

Member of Dongguan Anti-Cancer Association

Member of Dongguan Medical Association of Oncology

Academic achievement：

He has published many articles in various academic journals and won the Regional Science and Technology Award for his investigation and research on the distribution of nasopharyngeal carcinoma in Youjiang River area. He also published articles including"Clinical Analysis of 107 Cases of Radiotherapy for Nasopharyngeal Carcinoma", "Analysis of TSGF Results of 34 Cases of Nasopharyngeal Carcinoma Before and After Radiotherapy", and "Application and Progress of Nanotechnology in Interventional Therapy for Cancer".

Research technology:

Chemotherapy and radiotherapy

Minimally invasive therapy for tumor

Interventional therapy

Research area:

Tumor

*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.